Omega 3 Pet Supplement Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

The Omega-3 pet supplement market occupies a significant and fast-growing share of the global pet dietary supplements industry, which is projected to reach $7.4 billion by 2035 at a 6% compound annual growth rate. Within this broader category, omega-3 fatty acids, primarily eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and alpha-linolenic acid (ALA), serve as one of the most widely used functional ingredients due to clinically documented benefits for joint mobility, dermatological health, and cardiovascular function in companion animals. The market encompasses a diverse range of product formats including softgel capsules, liquid gels, chewables, and powder additives, with marine-sourced fish oil and krill oil dominating over plant-based alternatives in terms of bioactive potency.

• •The broader omega-3 market (across all applications) is valued at $3.922 billion in 2026 and expected to reach $5.75 billion by 2030, with pet supplements representing a meaningful and expanding segment.
• •Product formats span softgels, liquids, powders, and chewables, with marine-sourced EPA and DHA commanding the largest share due to superior bioavailability over plant-derived ALA.
• •Veterinary endorsement of omega-3 supplementation for osteoarthritis, skin conditions, and cognitive support in aging pets is a core demand driver.

Rising pet humanization, the trend of treating companion animals as family members, has substantially increased per-pet spending on preventive health and wellness products, including nutraceutical supplements. Veterinarians increasingly recommend omega-3 fatty acids as an evidence-based intervention for osteoarthritis, inflammatory skin disease, and age-related cognitive decline, lending clinical credibility to commercial product claims. Concurrently, growing awareness of ingredient sourcing, sustainability, and product purity is pushing manufacturers toward certified-sustainable marine oils and transparent supply chains.

• •Expanding companion animal populations and higher per-pet healthcare expenditures globally are lifting demand across North America, Europe, and the Asia-Pacific region.
• •Clinical validation of EPA and DHA for joint, skin, and cognitive health in dogs and cats underpins veterinarian-recommended product positioning.
• •Sustainability certifications and clean-label claims are becoming influential purchasing criteria for premium pet omega-3 products.

By source type, marine-derived ingredients, encompassing cold-water fish oil, krill oil, and algal oil, account for the dominant share of the market, owing to the direct bioavailability of EPA and DHA compared to shorter-chain plant-based alternatives such as flaxseed or canola oil. By pet type, dog-focused formulations represent the largest revenue segment, followed by cat-specific products, with equine and other companion animal applications forming a smaller but growing niche. Geographically, North America leads in market share driven by high pet ownership rates, well-developed veterinary infrastructure, and strong consumer spending power, while Western Europe represents the second-largest region with similarly mature demand.

• •Marine-sourced omega-3 dominates over plant-derived alternatives, with krill oil and algal oil gaining share due to sustainability positioning and reduced ocean contaminant risk.
• •Dog-specific formulations are the largest pet-type segment; cat and small-animal lines are expanding as product diversification accelerates.
• •North America holds the leading regional share, with Western Europe and Japan as mature secondary markets; the Asia-Pacific region is the fastest-growing area due to rising pet ownership in China, India, and Southeast Asia.

Who are the notable companies in the industry?

The competitive structure of the omega-3 pet supplement market is moderately fragmented, with a mix of large vertically integrated marine ingredient producers, specialty pet nutraceutical manufacturers, and private-label formulators serving the direct-to-consumer and veterinary channels. Integrated producers control upstream supply chains from wild-catch fisheries or aquaculture through refining and concentrating into finished omega-3 concentrates, while specialty pet health companies typically source bulk marine oils and formulate finished branded products. Among the major players, Nutramax Laboratories and VetriScience Laboratories are established participants in this space. Nordic Naturals leverages its human-grade extraction infrastructure to command premium shelf placement in veterinary channels, while Zesty Paws LLC competes through flavor-m

• •The market features a mix of integrated marine ingredient producers and specialty pet supplement formulators, with competitive differentiation built around sourcing certification, concentration levels, and delivery format innovation.
• •Upstream supply is concentrated in Peru, Chile, Norway, Iceland, and Denmark, key fishing zones for raw fish oil destined for omega-3 concentrate production.
• •Key process routes include wet reduction (cooking and pressing), solvent extraction, molecular distillation, and supercritical CO2 extraction, with molecular distillation remaining the most widely adopted industrial purification technology for achieving high EPA/DHA concentrations.

What are the recent trends and outlook?

The market is poised for sustained growth through 2030, underpinned by continued pet humanization, expanding scientific evidence linking omega-3 intake to measurable health outcomes in companion animals, and growing retailer support for shelf space allocation. Functional combination products, pairing omega-3 with glucosamine, chondroitin, or probiotics, are gaining traction as pet owners seek multi-benefit solutions. E-commerce and direct-to-consumer subscription models are reshaping channel dynamics, enabling emerging and niche brands to compete with traditional veterinary-clinic distribution. Environmental sustainability, traceability, and third-party testing for heavy metals and oxidation are expected to become minimum baseline expectations rather than premium differentiators.

• •Combination products that integrate omega-3 with joint-support or probiotic ingredients are emerging as a fast-growing product innovation category.
• •E-commerce and subscription-based direct-to-consumer models are accelerating market access and brand-building, particularly among younger pet-owner demographics.
• •Regulatory scrutiny around label accuracy, potency claims, and contaminant testing standards is increasing, raising the bar for product compliance and quality assurance globally.